ISAL 2019

The biennial International Symposium on Acute Leukemias is taking place in Munich. Bringing together researchers and clinicians, this meeting aims to improve our understanding of the biology and treatment of AML, ALL and APL.

Dive into the latest updates and expert insights, including the frontier of precision medicine, immunotherapies such as triplebodies and CiTEs, epigenetic heterogeneity and targeting, clonal interference and preleukemic clones, MRD quantification and application, and the unmet need of hematology patients in ICU.